UN&UP’s Transformational CorBot™ Electrophysiology System was Awarded Participation into the Prestigious C3i Program by the NIBIB, NHLBI, and Coulter Foundation
UN&UP’s transformational CorBot™ electrophysiology system was awarded participation into the prestigious C3i program by the NIBIB, NHLBI, and Coulter Foundation
UN&UP’s TheraLode™ nanoparticle thrombolysis platform for acute ischemic stroke selected to be part of the NIH’s Company Showcase at Life Science Summit
Un&Up’s TheraLode™ nanoparticle thrombolysis platform for acute ischemic stroke has been selected to be part of the NIH’s Emerging Company Showcase at the Life Science Summit in New York City!
UN&UP Announces the Newest Member of our Fellowship Program: Matthew DeVenecia
It’s with great excitement that we welcome Matthew DeVenecia to the team!
UN&UP Featured in the St. Louis INNO Chapter of The Business Journals for Efforts to Advance Stroke Treatment
We are honored to be featured in the most recent edition of St. Louis INNO’s chapter of The Business Journal.
UN&UP Receives Another Prestigious NIH Phase II SBIR Award from the NINDS for its Novel TheraLode™ Thrombolysis Platform
We are thrilled to share that UN&UP has been awarded its largest NIH Phase II SBIR award yet from the NINDS for developing our innovative TheraLode™ thrombolysis pharmaceutical platform for acute ischemic stroke.
UN&UP Announces Dr. Nicholas Jensen as our 2023 Medical Robotics Fellowship
It’s with great excitement that we welcome Nick Jensen, PhD, to the team!
UN&UP Announces the Hire of Gabrielle VanderVinne
It’s with great excitement that we announce the hire of Gabrielle VanderVinne!
UN&UP Selected to Present at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference
UN&UP is excited to announce that it was selected to present at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference
UN&UP Receives Its First Phase II Award from the NINDS
UN&UP receives its first Phase II award from the NINDS
